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Background: Klebsiella pneumoniae is a Gram-negative enteric 
bacterium that  causes nosocomial infections; this bacterium has 
survived from harsh condition using biofilm formation in hospital 
equipment and cause severe infection. In the other hand, the 
emergence and extension of carbapenem resistance burden among 
K. pneumonia producing biofilm is the current concern of public 
health services. There are controversial findings about this subject. 
The aim of this study was to evaluate the correlation between 
biofilm formation and resistance to carbapenem among clinical 
isolates of K. pneumoniae. 
Methods: A total of 160 K. pneumoniae isolates were collected 
from various infections of hospitalized patients. The Carba NP test 
and molecular methods were used for detection of carbapenem 
resistance isolates of K. pneumonia. Subsequently, the ability for 
biofilm production was performed from all isolates. Finally, 
Correlation of biofilm formation among carbapenem resistant 
isolates was calculated using χ2 and Fisher’s exact tests. 
Results: Among K. pneumoniae isolates 42.5% have 
carbapenemase activity by Carba NP test, while carbapenemase 
genes were detected in 35.6% of isolates in amplification assay. 
Moreover, there are 52.5% (n= 84) of all isolates were formed a 
strong biofilm, while 38.1% (n= 61) and 9.3% (n= 15) of isolates 
were middle and weak biofilm producer, respectively. Among 
carbapenem resistant cases (n= 68), there are 77.9% (n= 53) and 
22% (n= 15) of isolates were reported as strong and middle biofilm 
producer, respectively. We see a significant correlation was seen 
between biofilm formation ability and carbapenem resistant 
isolates (p-value < 0.00001). 
Conclusion: The increase of carbapenem resistance burden in 
biofilm producing isolates of K. pneumoniae is considered as 
serious alert and the basic measures to combat this phenomenon is 
imperative. 
















Due to the emerging and increasing antibiotic 
resistance, treatment of infectious diseases has 
become a major concern (1, 2). Decreasing speed 
of discovery of new antimicrobials into the market 
is led to emerging and rapid spreading of the drug 
resistant isolates. Hence, spreading of these drug 
resistant isolates is a serious threat to public health 
(1-4). Formerly, β-lactam antibiotics have been the 
main drug of treatment for infectious diseases due 
to gram negative bacilli, but are facing the 
antimicrobial resistance scenario (5). For example, 
extended-spectrum β-lactamase (ESBL)-producing 
isolates has increased worldwide spread with 
significant morbidity and mortality (6, 7). In this 
regard, carbapenems have been introduced for 
next choice against drug resistant isolates. This 
antibiotic family has the broadest activity spectra 
and is still the most active drugs against ESBL 
producing Enterobacteriaceae (8, 9). 
Unfortunately, carbapenem-resistant Klebsiella 
pneumoniae strains have been emerging and were 
spreading worldwide which cause limiting 
chemotherapy in various infections (10, 11). 
K. pneumoniae is one of the most 
common human pathogen which is recovered from 
a wide range of community and hospital acquired 
infections such as pneumonia, bacteremia, urinary 
tract and respiratory tract infections (12). The 
major virulence factors of K. pneumoniae are 
capsule, fimbriae, lipopolysaccharides (LPS), and 
biofilm formation (4). Concern about biofilm 
formation of K. pneumoniae are associated with 
colonization of this bacterium in many medical 
conditions including indwelling medical devices, 
upper respiratory tract infections, peritonitis, and 
urogenital infections (13). The bacterial 
population can survive in harsh conditions within 
host, by the formation of biofilm.  (14). 
Importantly, it has been reported that 
about 40% of biofilm producing K. pneumoniae 
were recovered not only from urine but also from 
blood, sputum and wound swabs (15). Specific 
physiological and genetically interactions within 
the biofilm are causing a dramatic increase of 
antimicrobial resistant agents. (16). 
Previously studies have shown various 
associations between antibiotic resistance and 
biofilm formation. In this case, some researchers 
were reported that increased resistance was 
correlated with high biofilm production (17, 18), 
while other studies reported that biofilm formation 
decreased in high resistance isolates (19, 20). 
Taken together, the association between antibiotic 
resistance and biofilm formation is currently 
unclear and remains under investigation (21, 22). 
The increasing incidence of ESBL and 
carbapenemase-producing strains of K. 
pneumoniae in health care facilities is a cause of 
global concern. This scenario is exacerbated when 
these strains grow as a biofilm, causing a dramatic 
increase in the resistance to antimicrobial agents 
(16). Therefore, the aim of this study was 
evaluation of correlation between biofilm 
formation and resistance to carbapenem among 
clinical isolates of K. pneumoniae. 
 
MATERIALS AND METHODS 
 
Bacterial Strains: A total of 160 K. pneumoniae 
isolates was collected from various infections of 
hospitalized patients between  April 2018 and 
March 2019  at Army hospitals. Identification of 
bacterial isolates was performed using phenotypic 
and biochemical tests according to standard 
methods (23). 
Phenotypic Screening of Carbapenemase 
Enzymes: The Carba NP test was used for 
detection of carbapenemase activity according to 
standard protocol (24). Briefly, all isolates were 
grown overnight on Mueller-Hinton agar. One 
loop of the bacterial colonies was suspended in a 
1.5-ml micro tube containing 0.1 ml of 
20mMTris-HCl lysis buffer and mixed very well. 
This lysate was mixed with 0.1ml of indicator 
solution consisting of 0.05% phenol red with 0.1 
mmol/liter ZnSO4, which was previously adjusted 
to pH 7.8, and 6 mg/ml imipenem and, as a control 
tube, the phenol red solution without antibiotic. 
Finally, tubes were incubated at 35°C for 2 h. after 
that, color change from red to orange/yellow in the 
antibiotic-containing tube, which was interpreted 
as a positive result. K. pneumoniae ATCC BAA-
1705 was used as a positive control (24). 
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Table 1: Primers used to identify carbapenem resistant genes 
 
Reference PCR product Primer 1ESBLs  
)13( 188 Imp-F 5′-GGA ATA GAG TGG CTT AAY TCT C-3′ 
′3-CCA AAC YAC TAS GTT ATC T-R 5′-Imp 
IMP 
)3( 390 3′-GAT GGT GTT TGG TCG CAT A-F 5′-Vim 
3′-CGA ATG CGC AGC ACC AG-R 5′-Vim 
VIM 




)4( 743 3′-TTGGTGGCATCGATTATCGG-5′48F-OXA 
3′-GAGCACTTCTTTTGTGATGGC-5′48R-OXA 
OXA-48 
4)( 796  KPC-1F5′-CGTTCTTGTCTCTCATGGCC-3′ 
KPC-1R5′-CCTCGCTGTGCTTGTCATCC-3′ 
KPC- 
1extended spectrum β-lactamase 
 
Detection of Carbapenemase-Related Genes: 
Chromosomal DNA was extracted using a simple 
boiling method (25). Polymerase chain reaction 
was performed using specific primers to detect 
genes encoding carbapenemase enzymes (blaIMP, 
blaVIM, blaNDM, blaKPC, and blaOXA-48-like), 
as previously described (3). The PCR products 
were separated by electrophoresis in 1% agarose 
gel with 1× TBE (Tris/ borate/EDTA) buffer 
which stained with safe stain load dye (CinnaGen 
Co., Tehran, Iran) and finally was visualized under 
ultraviolet illumination. 
Biofilm assay: Biofilm formation ability of all 
isolated performed according to the described 
method previously. Briefly, in 96 cells microplate, 
isolates were incubated in Luria broth (LB) at 
37°Cfor 18 h. Then 200 µl of TSB was transferred 
to every well of the sterile microplate, then 10 µl 
of adjusted 0.5 McFarland bacterial suspension 
was added into the wells and was incubated at 37 
°C for 24 h. After incubation, supernatant 
discharged from the wells and was washed 3 times 
with saline. Then 200 µl of 1% crystal violet was 
added for 20 min into the wells and was washed 3 
times with saline and dried. Finally, 200 µl of 
DMSO was added to each well and the plate was 
examined by ELISA Plate Reader at 595 nm 
wavelength. Each test was repeated three times 
(26). 
 
Table 2. Biofilm formation ability and carbapenem resistant genes 
Bla1VIM blaIMP blaOXA48 like blaNDM 
Strong Middle Weak Strong Middle Weak Strong Middle Weak Strong Middle Weak 
29 3 - 7 2 - 11 4 - 1 - - 
1bla: beta lactamase 
 
The ability to produce biofilm was considered in 
four categories: 
Group 1: strong biofilm OD > 0.5. 
Group 2: middle biofilm 0.5 > OD > 0.3. 
Group 3: weak biofilm OD < 0.3. 
Group 4: Lack of biofilm OD < 0.15. 
Statistical Analysis: Correlation of biofilm 
formation among resistant and susceptible isolates 
was calculated using χ23ef and Fisher’s exact tests 
in SPSS software. p-values ≤0.05 were considered 
to be statistically significant. 
RESULTS 
 
Carbapenemase producing isolates: Among 160 
K. pneumoniae isolates 42.5% (n: 68) were 
carbapenemase producer by phenotypic method, 
while carbapenemase genes were detected in 
35.6% (n: 57) of isolates by molecular method. 
Distribution of carbapenemase genes among 
carbapenem resistant cases (n: 68) were blaVIM 
47% (n: 30), blaOXA-48-like 22% (n: 15), blaIMP 
13.2% (n: 9) and blaNDM 1.4% (n: 1). blaKPC gene 
was detected in isolates 2/9% (n:2) (Figure 1). 








Figure1: Images related to genotypic study of cluster colonies with carbapenem resistant genes. 
Klebsiella pneumonia 8053 AO (KPC gene transporter), Pseudomonas aeruginosa 510 PO (IMP, VIM), 
Escherichia coli 01 MH (NDM gene carrier), Klebsiella pneumonia 1514 Kp (OXA48 transporter) as positive 
control. 
 
Biofilm producing isolates: According to our 
results, 52.5% (n: 84) of all isolates were formed 
strong biofilm, while 38.1% (n: 61) and 9.3% (n: 
15) of isolates were middle and weak biofilm 
producer, respectively. Totally, from 92 
carbapenem sensitive cases, 33.6% (n: 31), 50% 
(n: 46) and 16.3% (n: 15) were strong, middle and 
weak biofilm producer. But, among carbapenem 
resistant cases (n: 68), 77.9% (n: 53) and 22% (n: 
15) of isolates were reported as a strong and 
middle biofilm producer, respectively. Also, 
among carbapenem phenotypical resistant cases 
(no carbapenemase gene detected) 5 and 6 isolates 
showed strong and middle biofilm formation 
ability.  A weak biofilm producer has not been 
seen in carbapenem resistant case. In this regard, a 
significant correlation had seen between biofilm 





In the present study, the correlation between 
biofilm formation and resistance to carbapenem 
among clinical isolates of K. pneumoniae was 
evaluated. According to our results, s frequent 
gene among carbapenem resistant isolates was 
blaVIM, but only one isolates harbored the blaNDM 
gene. It has been reported that blaVIM gene is more 
frequent than the blaIMP gene (26). Also, 
Hosseinzadeh et al. (27), was reported that more 
than 10% of the isolates carried the blaNDM-1 
gene. The blaKPC gene was not detected in any of 
our strains. 
Interestingly, a significant correlation has been 
seen between carbapenem resistance and biofilm 
formation ability of the isolates. Although among 
carbapenem sensitive isolates, a strong biofilm 
producer were seen, but majority of carbapenem 
resistant isolates were strong biofilm producers. In 
this case, it has been reported that some 
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correlations exist between biofilm-formation and 
antibiotic resistance among K. pneumoniae strains. 
For example, among 150 K. pneumoniae strains, 
isolated from sputum and urine, significant 
association has been seen among biofilm 
formation with ESBL production (15). Another 
study was showed that, MDR K. pneumoniae 
strains are form a richer biofilm rather than 
susceptible ones (28). According to Khodadadian 
et al in 2018, significant correlation was seen 
between strong biofilm formation and prevalence 
of VIM1 and IMP1 genes (26).  
In some cases, antibiotic resistance genes are 
responsible for this phenomena correlation. It has 
been demonstrated that, resistance genes in special 
plasmids can regulate biofilm formation in K. 
pneumoniae strains (29). 
In conclusion, the acquisition of specific 
antibacterial resistance can compromise or 
enhance biofilm formation among the bacterial 
population. Therefore, the increasing prevalence 
of drug resistant and biofilm producer K. 
pneumoniae, mostly in hospital associated setting 
and our data supporting the correlation of biofilm 
formation with the antibiotic resistance acquisition 
should alert even more regarding the concern 
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